ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS,more
Developer an ear surgery device designed to create various versions of sterile endoscopy in ENT. The company's device offers a sterile endoscope for complex ear surgery to address the significant challenges in the usability and flexibility of endoscopes, enabling surgeons to gain the benefits of endoscopic visualization while maintaining their two-handed operating technique.
Developer of electrophysiology and structural heart devices designed to treat patients suffering from complex chronic cardiac, stroke and arrhythmia risk diseases. The company's devices are built around custom left atrial appendage occluder implants that provide synergistic modules like cardiac monitoring, ablation, or both modules, enabling medical professionals to offer cost-benefit treatments without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.